Samsung Biologics' pending PolyPeptide deal adds peptide API manufacturing, including GLP-1 supply, to its antibody and ADC CDMO services.
|Articles|March 12, 2008
Gary Swan Appointed VP of Operations at Laureate Pharma
Author(s)BioPharm International Editors
Laureate Pharma, Inc. (Princeton, NJ), has appointed Gary Swan vice president of operations.
Advertisement
Laureate Pharma, Inc. (Princeton, NJ), has appointed Gary Swan vice president of operations. Swan will be responsible for leading Laureate’s manufacturing operations, which include upstream processing, downstream processing, formulation and filling, facilities maintenance, and environmental, health, and safety regulations.
Laureate release
Advertisement
Related to this article
The deal gives Fresenius options on biosimilars spanning monoclonal and bispecific antibodies, ADCs, and fusion proteins, starting with polatuzumab vedotin and teprotumumab, and could expand its portfolio from 29 to 66 molecules.
FDA set a May 1, 2027 target date for AMT-130, a one-time gene therapy that silences the huntingtin gene, and plans an advisory committee meeting.
Inovio reports that Voceryq spared 27% of adults with recurrent respiratory papillomatosis from surgery for 12 months in a 26-patient efficacy group.
Three case studies show how automated Raman plate reading can triage samples before chromatography in bioprocess development.
This year’s AAPS PharmSci 360 highlighted AI transparency, computer modeling in formulation, oral peptide delivery, and new business models.
FDA approves Sun Pharma’s Ilumya for active psoriatic arthritis, BioMarin licenses a subcutaneous Fabry enzyme replacement therapy from GC Biopharma and Hanmi, and Lonza expands bioconjugation capacity in Visp to meet rising ADC demand.
In an interview for BioPharm International’s AAPS PharmSci 360 2026 coverage, Nanoform’s Chris Worrall shares 18-month stability data for a 440 mg/mL trastuzumab suspension and explains how ultra-high-concentration formulations could shorten administration and support at-home injection.
Advertisement
Advertisement
Trending on BioPharm International
1
Drug Digest: Reshoring Manufacturing and Securing Cold-Chain Supply for Biopharma
2
Lonza Adds Bioconjugation Suites in Visp to Meet Rising ADC Demand
3
Resolving the Speed-Specificity Trade-Off in Biopharma High-Throughput Screening
4
Leads Biolabs Doses First Lupus Patient With LBL-047, a BDCA2/TACI Bifunctional Fusion Protein
5